Severe bone marrow failure due to low dose oral methotrexate
Buchbinder, R.; Hall, S.; Ryan, P.F.; Littlejohn, G.O.; Harkness, A.J.
Journal of Rheumatology 15(10): 1586-1588
1988
ISSN/ISBN: 0315-162X PMID: 3204605 Document Number: 326131
Document emailed within 1 workday
Related Documents
Bowen, D.; Southerland, W.M.; Johnson, D.H.; Hawkins, M.; Hughes, D.E. 2000: Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells Cancer Detection and Prevention 24(5): 452-458Tsurusawa, M.; Sasaki, K.; Matsuoka, H.; Katano, N.; Fujimoto, T. 1985: Studies on high-dose methotrexate with citrovorum factor rescue therapy in children: analysis of bone marrow cell kinetics by flow cytometry Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(9): 1827-1832
Milliken, S.; Powles, R.; Jones, A.; Helenglass, G. 1989: Pharmacokinetics of oral fluconazole in autologous bone marrow transplantation recipients given TBI and high-dose melphalan Transplantation Proceedings 21(1 Pt 3): 3067
Kessinger, A.; Vose, J.M.; Bierman, P.J.; Armitage, J.O. 1991: High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging Experimental Hematology 19(10): 1013-1016
Lehn, P.; Quessar, A.; Devergie, A.; Esperou-Bourdeau, H.; Traineau, R.; Trédaniel, J.; Benbunan, M.; Bussel, A.; Jolivet, I.; Mazeron, M.C. 1990: Treatment of severe cytomegalovirus infection with ganciclovir and high-dose intravenous immunoglobulin in patients with allogeneic bone marrow transplants. a pilot study Nouvelle Revue Francaise d'Hematologie 32(1): 17-20
Davies, S.M.; Weisdorf, D.J.; Haake, R.J.; Kersey, J.H.; McGlave, P.B.; Ramsay, N.K.; Blazar, B.R. 1994: Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation Bone Marrow Transplantation 14(1): 73-77
Jundt, J.W.; Browne, B.A.; Fiocco, G.P.; Steele, A.D.; Mock, D. 1993: A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing Journal of Rheumatology 20(11): 1845-1849
Köppler, H.; Pflüger, K.H.; Havemann, K. 1991: High-dose chemotherapy with autologous bone marrow rescue: haematopoietic reconstitution by non-cryopreserved marrow Bone Marrow Transplantation 7(Suppl 2): 143
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Rozman, C.; Grañena, A.; Marín, P.; Hernández-Prieto, M.; Nomdedeu, B.; Montserrat, E.; Feliu, E.; Bladé, J.; Cervantes, F.; Vives Corrons, J.L. 1985: Allogeneic marrow transplantation in severe bone marrow aplasia. Factors determining the outcome in a series of 27 consecutive cases Medicina Clinica 84(4): 129-134
Chamot, A.M.; Gerster, J.C.; Van Melle, G. 1988: Low-dose oral methotrexate in the treatment of rheumatoid polyarthritis Schweizerische Medizinische Wochenschrift 118(36): 1267-1271
Isasi, C.; López-Martín, J.A.; Angeles Trujillo, M.; Andreu, J.L.; Palacio, S.; Mulero, J. 1989: Felty's syndrome: response to low dose oral methotrexate Journal of Rheumatology 16(7): 983-985
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
Hantaweepant, C.; Chinthammitr, Y.; Khuhapinant, A.; Sukpanichnant, S. 2016: Clinical Significance of Bone Marrow Involvement as Confirmed by Bone Marrow Aspiration vs. Bone Marrow Biopsy in Diffuse Large B-cell Lymphoma Journal of the Medical Association of Thailand 99(3): 262-269
Pu, Q.; Tang, C.S.; Zhou, R.H. 1991: A histopathological study of bone marrow in acute myeloid leukemia. Bone marrow biopsy changes before chemotherapy and comparison with bone marrow smears Zhonghua Nei Ke Za Zhi 30(9): 566-568; 595
Bergasa, N.V.; Jones, A.; Kleiner, D.E.; Rabin, L.; Park, Y.; Wells, M.C.; Hoofnagle, J.H. 1996: Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis American Journal of Gastroenterology 91(2): 295-299
Tepmongkol, P. 1979: Large intravenous dose of methotrexate and radiotherapy in the treatment of advanced oral cancers Journal of the Medical Association of Thailand 62(1): 17-25
El Miedany, Y.M.; Abubakr, I.H.; El Baddini, M. 1998: Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis Journal of Rheumatology 25(11): 2083-2087
Marmont, A.M. 1979: Transplantation haemopoiesis. Morphological bone marrow studies after allogeneic marrow transplantation in man for severe aplastic anaemia and acute leukaemia Nouvelle Revue Francaise d'Hematologie 21(2): 133-148
Bengtsson, G.; Bryman, I.; Thorburn, J.; Lindblom, B. 1992: Low-dose oral methotrexate as second-line therapy for persistent trophoblast after conservative treatment of ectopic pregnancy Obstetrics and Gynecology 79(4): 589-591